Skip to content

Clinical trials

Phase 2 Lymphoma, Mantle-Cell trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Mantle-Cell Phase: Phase 2 Country / region: Spain Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20091
20111
20121
20131
20152
20161
20172
20191
20212
20222
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting6
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea4
AstraZeneca3
Celgene2
Janssen Research & Development, LLC2
Acerta Pharma BV1
CABYC1
Cellectar Biosciences, Inc.1
Incyte Corporation1
Kite, A Gilead Company1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Mantle-Cell19
Lymphoma5
Lymphoma, Follicular4
Lymphoma, Large B-Cell, Diffuse4
Lymphoma, Non-Hodgkin4
Lymphoma, B-Cell, Marginal Zone3
Recurrence3
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma, B-Cell2
Blood Protein Disorders1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.